Accessibility Menu
Guardant Health logo

Guardant Health

(NASDAQ) GH

Current Price$140.35
Market Cap$17.35B
Since IPO (2018)+306%
5 Year+4%
1 Year+169%
1 Month+10%

Guardant Health Financials at a Glance

Market Cap

$17.35B

Revenue (TTM)

$1.08B

Net Income (TTM)

-$433.19M

EPS (TTM)

-$3.40

P/E Ratio

-38.48

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$140.35

Volume

42,856

Open

$132.68

Previous Close

$130.83

Daily Range

$132.66 - $140.92

52-Week Range

$40.36 - $140.92

Estimated Earnings Date

Jul 29, 2026

GH: Motley Fool Moneyball Superscore

79

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guardant Health

Industry

Healthcare Providers and Services

Employees

2,506

CEO

Helmy Eltoukhy, PhD; AmirAli H. Talasaz, PhD

Headquarters

Palo Alto, CA 94063, US

GH Financials

Key Financial Metrics (TTM)

Gross Margin

64.90%

Operating Margin

-41.43%

Net Income Margin

-40.10%

Return on Equity

184.27%

Return on Capital

-27.09%

Return on Assets

-22.62%

Earnings Yield

-2.60%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.35B

Shares Outstanding

132.60M

Volume

42.86K

Avg. Volume

2.24M

Financials (TTM)

Gross Profit

$701.01M

Operating Income

-$447.56M

EBITDA

-$390.98M

Operating Cash Flow

-$175.41M

Capital Expenditure

-$49.43M

Free Cash Flow

-$224.83M

Cash & ST Invst.

$1.10B

Total Debt

$1.70B

Guardant Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$301.67M

+48.3%

Gross Profit

$196.75M

+52.8%

Gross Margin

65.22%

N/A

Market Cap

$17.35B

N/A

Market Cap/Employee

$8.68M

N/A

Employees

1,999

N/A

Net Income

-$112.08M

-17.8%

EBITDA

-$100.91M

-20.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.10B

+57.9%

Total Debt

$1.70B

+30.5%

Accounts Receivable

$137.40M

+19.0%

Inventory

$83.85M

+8.5%

Long Term Debt

$1.68B

+31.3%

Short Term Debt

$28.03M

-5.5%

Return on Assets

-22.62%

N/A

Return on Invested Capital

-27.57%

N/A

Free Cash Flow

-$71.20M

-6.0%

Operating Cash Flow

-$65.62M

-4.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VTRSViatris Inc.
$15.89+0.91%
ASNDAscendis Pharma A/S
$238.61+0.01%
EXASExact Sciences Corporation
$104.91+0.00%
BBIOBridgeBio Pharma, Inc.
$70.53+2.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.99+0.28%
NOKNokia
$13.87+0.01%
PLSMPulsenmore
$8.69+1.55%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.28+0.01%

Questions About GH

What is the current price of Guardant Health?

Guardant Health is trading at $140.35 per share.

What is the 52-week range for Guardant Health?

Over the past 52 weeks, Guardant Health has traded between $40.36 and $140.92.

How much debt does Guardant Health have?

As of the most recent reporting period, Guardant Health reported total debt of $1.70B.

How much cash does Guardant Health have on hand?

Guardant Health reported $989.29M in cash and cash equivalents in its most recent financial results.

What is Guardant Health’s dividend yield?

Guardant Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.